Northwest Hospital, formerly known as Northwest Hospital Center and Baltimore County General Hospital before that, is a hospital in Randallstown, Maryland owned and operated by LifeBridge Health. The hospital is full-service, with an emergency department and surgical facilities.

There are 202 beds in Northwest Hospital Center.

During the past decade, Northwest Hospital Center conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 27 clinical trials were completed, i.e. on average, 67.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 22 clinical trials were completed. i.e. 244.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Hospital Center" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Celularity Incorporated" with 5 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Hospital Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer" (4 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Northwest Hospital Center" in a lesser frequency.

Most popular intervention types in "Northwest Hospital Center" are "Drug" (41 trials), "Other" (35 trials), "Biological" (21 trials), "Procedure" (9 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (14 trials), "Docetaxel" (9 trials), "Nivolumab" (8 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Hospital Center" are 44 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Northwest Hospital Center". undefined are not yet recruiting, 11 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Northwest Hospital Center, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Hospital Center, 1 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".